EasySep™小鼠TIL（CD45）正选试剂盒
搜索结果: 'methocult media formulations for mouse hematopoietic cells serum containing'
-
STEMCELL Technologies Inc. to Host Stem Cell Training Courses STEMCELL Technologies has announced the schedule for their fall training program -
STEMCELL Technologies to Commercialize BrainPhys™ Neuronal Culture Medium for Improved Support of Neurophysiological Activity STEMCELL Technologies has announced that it has signed a license agreement with the Salk Institute for Biological Studies for the rights to commercialize BrainPhys™ Neuronal Medium -
STEMCELL Technologies Launches Innovative Products to Support CAR T Cell Research STEMCELL Technologies Inc. announces the launch of ImmunoCult™ Human T Cell Activator reagents and ImmunoCult™-XF T Cell Expansion Medium to support T cell researchers in their goal to develop CAR T cell immunotherapeutics -
STEMCELL Technologies Signs Exclusive License Agreement with Cincinnati Children’s for Stem Cell-Derived Organoid Technology This agreement grants STEMCELL a license to novel methods for generating organoid models and to develop cell culture media and tools that would enable scientists to create organoids from PSCs in their own laboratories -
New Video: Untouched cells in one step with RosetteSep™ STEMCELL Technologies is proud to present an exciting new video showcasing RosetteSep™, a one-step cell separation procedure by negative selection -
ENKAM Pharmaceuticals A/S Commercial Partnership with STEMCELL Technologies Inc ENKAM Pharmaceuticals A/S (ENKAM), a privately held Danish biopharmaceutical development company focused on cancer and central nervous system disorders, is pleased to announce that it has signed a licensing and development agreement with STEMCELL Technologies Inc. -
STEMCELL Technologies Inc. Obtains License from iPS Academia Japan for Induced Pluripotent Stem Cell Technologies STEMCELL Technologies has signed a patent license agreement with iPS Academia Japan, Inc. to license and commercialize iPS Academia Japan, Inc.'s patented technologies for induced pluripotent stem cell (iPS cell) research -
STEMCELL Technologies Receives ISO 13845:2003 Certification STEMCELL Technologies Inc (STEMCELL), a leader in specialty cell culture media, cell separation products and ancillary reagents for life science research, is pleased to announce that it has successfully achieved ISO 13485:2003 certification for its research, manufacturing and shipping facilities in Vancouver, BC, Canada and Tukwila, WA, USA
